09.01.21
Hims & Hers, the multi-specialty telehealth platform that provides modern and personalized health and wellness experiences, has appointed Mike Chi as the Company’s first-ever chief growth officer.
Chi, a Columbia University alum, joined the team at Hims & Hers earlier this year. He brings a wealth of expertise across marketing, strategy, positioning, and product, with specific emphasis on the women’s market. Previously, he served as the chief marketing officer at Zola and held senior positions at Intermix and Gilt Groupe.
“Mike has a proven record of delivering strong results, specifically when it comes to driving growth in traditionally women’s focused markets,” said Andrew Dudum, Hims & Hers chief executive officer. “Mike will help lead the charge as we look to continue delivering robust growth in our established Hims categories and double down on our emerging new Hers-focused specialties, such as Mental Health and Dermatology. He is truly a unique mind with a relentless work-ethic and expertise in channel level marketing that is rarely seen in marketing leaders.”
In Chi’s role as chief growth officer, he will be responsible for driving continued growth across an expanding number of telehealth specialties. His appointment comes on the heels of Hims & Hers’ strong reported Q2 earnings in 2021. In 2020, revenue grew by 80%. In Q1 and Q2 of 2021, revenue grew year-over-year by 74% and 69%, respectively, exceeding guidance and resulted in the company’s increase of full-year expectations. As of Q2, Hims & Hers has grown subscriptions year-over-year by 76% to 453,000 as it continues to focus-in on expanding core services and investing in newer ones.
Women’s hair and skin care and mental health services are among the Company’s fastest-growing categories, and company officials say Chi is well-positioned to sustain that growth. What’s more, 80% of customers are first-time buyers, whose benefit from the Company’s high quality, personalized and accessible healthcare.
Hims & Hers recently acquired Apostrophe, a teledermatology specialist and compounding pharmacy, to expand its investment in the growing dermatology vertical. It also acquired Honest Health, a London-based vertical health platform, to lay the foundation for future expansion in the United Kingdom and Europe.